Pharma Nord is one of Europe’s largest manufacturers of products with essential nutrients. We develop, manufacture and market scientifically well founded dietary supplements, herbal remedies and medical drugs based on optimal bio-availability, safety and documentation.

The products are tested actively in scientific research and to date more than 300 scientific studies are published with Pharma Nord's products, including the sensational Q-Symbio and KiSel-10 studies, that shows how effectively you can treat and prevent using coenzyme Q10 and selenium.

Pharma Nord’s research database contains more than 9,000 scientific studies - including all the studies conducted with Pharma Nord’s own preparations. The database is the cornerstone of the entire product development.

With its production facilities and company head quarters located in Denmark, Pharma Nord has a large operational field. Pharma Nord’s products are represented in Europe, the Middle East and in the rapidly expanding markets of Asia, Russia and the United States, through 25 daughter companies and 20 business partners.

Pharma Nord is a privately owned limited company.


Pharma Nord manufactures all our products in Denmark and is subject to the restrictive Danish laws. Because our legislation is highly respected by markets abroad, Pharma Nord has chosen to meet the increased demand for our products by expanding our Danish production facilities in Denmark, instead of moving part of our production to other countries.

Pharma Nord's production and storage facilities is located in Vojens, just 50 kilometers from the Danish-German border. Here we are expanding regularly. This way we ensure the production capacity and also ensure optimal conditions for future growth and development.


Pharma Nord’s products have become a well-known brand in many countries, particularly because of the characteristic design with its well-known "quality beacon", the golden mortar and its "peep-hole" to the products inside, the exclusive, gold-rimmed boxes and the uniform Bio-concept. Consumers, retailers and health professionals associate these traits with thorough research and a high level of bio-availability and safety. These virtues are what make Pharma Nord’s preparations viable in a market that is often ruled by trends. In fact, this is what prompted the international Superbrand Council to nominate Pharma Nord "Superbrand 2007" within the Business-to-Consumer market.


Pharma Nord and several other branch colleagues have established Nutraceutical Industry (NI), an association of leading nutraceutical suppliers. The primary task of NI is to bridge the gap between the two sharply separated sectors for pharmaceutical drugs and food. This is done by engaging in a constructive dialogue with authorities, experts and consumer organizations on matters relating to the industry's development and image. Sven Moesgaard, Pharma Nord's technical director, was Nutraceutical Industry's first chairman and still sits on the board.


Pharma Nord was founded in 1982 by the two current owners, Eli Wallin and Sven Moesgaard, who established an import of a British selenium product. Soon after, the product was developed additionally and ended up as the product known as Bio-Selenium®+Zinc, which is still a cornerstone of the product range.

The underlying idea of Pharma Nord was to compensate for the shortcomings of modern diet by means of dietary supplements with high a bio-availability and a documented effect. Bio-Selenoium®+Zinc successfully embedded this philosophy in a single product and paved the road for the first daughter companies that were established in Sweden, England and Finland

Over the years, Pharma Nord has earned a reputation as an innovative and visionary player on the nutraceutical market on several occasions. Phama Nord was the first company to introduce coenzyme Q10 to the European market. Its product Bio-Quinone Q10 was launched in 1990 and has grown to become one of the leading Q10 products worldwide. This is just one of many examples showing how Pharma Nord has spearheaded the market by channelling new knowledge into new products.

Pharma Nord's products are currently retailed in more than 45 countries. Approximately 85% of the companys products are registered as medical drugs of some kind in one or several countries. This is the reason why all products - including dietary supplements - not only are produced according to GMP (Good Manufacturing Practice), but in fact according to the guidelines for production of medical drugs.

The combination of documented products and exclusive retail through retailers and pharmacies has ensured Pharma Nord notable success and worldwide recognition. Over the years, Pharma Nord has received a number of honorary awards from branch and retail organisations on the different markets. 



  • Oeuvre Award (Lifetime Achievement Award): Holland 2007
  • Superbrand of the Year on the B2C market (nominated) 2007
  • Pharma Nord Bulgaria: Product of the Year:
  • Most informative campaign
  • Primmuno: Most Innovative Product 2009 Belgium
  • Pharma Nord Holland: Best Release 2009
  • BioActive Q10: Best New Product 2010
  • Pharma Nord Portugal: Slim Duo: Product of the year 2011
  • Pharma Nord Holland: Supplier of the year 2012
  • Bio-Quinon GOLD: Product of the year 2014  Finland
  • Pharma Nord Finland: Supplier of the year 2014
  • Pharma Nord U.K. Bio-Chromium, Best supplement 2014

Product of the Year Holland


CLA-T - The year product in Bulgaria

CLA-T - The year product in Portugal

CLA-T - Bedst product in Poland
for six consecutive years(2007-12)